| Brijesh S Gill, MD | |
|
800 E Dawson St, Tyler, TX 75701-2036 | |
| (903) 606-6400 | |
| (903) 606-1522 |
| Full Name | Brijesh S Gill |
|---|---|
| Gender | Male |
| Speciality | Surgery |
| Location | 800 E Dawson St, Tyler, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346279502 | NPI | - | NPPES |
| 158241301 | Medicaid | TX | |
| 8F6695 | Other | TX | BCBS |
| 158241307 | Medicaid | TX | |
| 1L0846 | Other | VA | MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0102X | Surgery - Surgical Critical Care | K9284 (Texas) | Secondary |
| 208600000X | Surgery | K9284 (Texas) | Primary |
| Entity Name | Ut Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033157821 PECOS PAC ID: 8426960360 Enrollment ID: O20031107000268 |
News Archive
A novel anti-interleukin 1-alpha antibody has shown a significant impact on symptoms, and a high level of safety and tolerability in patients with advanced colorectal cancer, according to phase III data presented at the European Society for Medical Oncology's 18th World Congress of Gastrointestinal Cancer in Barcelona, Spain.
The American College of Physicians' Medical Laboratory Evaluation (MLE) program recently gained approval to offer certain analytes for use with the College of American Pathologists (CAP) Laboratory Accreditation Program (LAP). The CAP accreditation program is an internationally-recognized program that uses more rigorous standards than regulatory compliance to help labs achieve the highest standard of excellence. In order to qualify for accreditation, labs must perform proficiency testing on required analytes.
There's been a fivefold rise in the number of young children requiring treatment after having swallowed a magnet over the past 5 years in the UK, suggests data from specialist doctors in a letter published online in the Archives of Disease in Childhood.
Can a drug that has been used to treat malaria for years possibly be used to treat breast cancer before it becomes invasive? That's what researchers at George Mason University's Center for Applied Proteomics and Molecular Medicine (CAPMM) and Inova Breast Care Institute (IBCI) are trying to prove.
Stiffer breast tissue creates an environment more prone to cancer by enabling the disease to interfere with the surrounding healthy cells, according to a recent study published in Biomaterials.
› Verified 5 days ago
| Entity Name | Christus Trinity Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285684225 PECOS PAC ID: 3072426741 Enrollment ID: O20031204001091 |
News Archive
A novel anti-interleukin 1-alpha antibody has shown a significant impact on symptoms, and a high level of safety and tolerability in patients with advanced colorectal cancer, according to phase III data presented at the European Society for Medical Oncology's 18th World Congress of Gastrointestinal Cancer in Barcelona, Spain.
The American College of Physicians' Medical Laboratory Evaluation (MLE) program recently gained approval to offer certain analytes for use with the College of American Pathologists (CAP) Laboratory Accreditation Program (LAP). The CAP accreditation program is an internationally-recognized program that uses more rigorous standards than regulatory compliance to help labs achieve the highest standard of excellence. In order to qualify for accreditation, labs must perform proficiency testing on required analytes.
There's been a fivefold rise in the number of young children requiring treatment after having swallowed a magnet over the past 5 years in the UK, suggests data from specialist doctors in a letter published online in the Archives of Disease in Childhood.
Can a drug that has been used to treat malaria for years possibly be used to treat breast cancer before it becomes invasive? That's what researchers at George Mason University's Center for Applied Proteomics and Molecular Medicine (CAPMM) and Inova Breast Care Institute (IBCI) are trying to prove.
Stiffer breast tissue creates an environment more prone to cancer by enabling the disease to interfere with the surrounding healthy cells, according to a recent study published in Biomaterials.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brijesh S Gill, MD Po Box 301173, Dallas, TX 75303-1173 Ph: (713) 500-3500 | Brijesh S Gill, MD 800 E Dawson St, Tyler, TX 75701-2036 Ph: (903) 606-6400 |
News Archive
A novel anti-interleukin 1-alpha antibody has shown a significant impact on symptoms, and a high level of safety and tolerability in patients with advanced colorectal cancer, according to phase III data presented at the European Society for Medical Oncology's 18th World Congress of Gastrointestinal Cancer in Barcelona, Spain.
The American College of Physicians' Medical Laboratory Evaluation (MLE) program recently gained approval to offer certain analytes for use with the College of American Pathologists (CAP) Laboratory Accreditation Program (LAP). The CAP accreditation program is an internationally-recognized program that uses more rigorous standards than regulatory compliance to help labs achieve the highest standard of excellence. In order to qualify for accreditation, labs must perform proficiency testing on required analytes.
There's been a fivefold rise in the number of young children requiring treatment after having swallowed a magnet over the past 5 years in the UK, suggests data from specialist doctors in a letter published online in the Archives of Disease in Childhood.
Can a drug that has been used to treat malaria for years possibly be used to treat breast cancer before it becomes invasive? That's what researchers at George Mason University's Center for Applied Proteomics and Molecular Medicine (CAPMM) and Inova Breast Care Institute (IBCI) are trying to prove.
Stiffer breast tissue creates an environment more prone to cancer by enabling the disease to interfere with the surrounding healthy cells, according to a recent study published in Biomaterials.
› Verified 5 days ago
Hugh P Babineau, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1100 E Lake St, Ste 230, Tyler, TX 75701 Phone: 903-593-0230 Fax: 903-597-3015 | |
Dr. David Brent Kerns, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1040 S Fleishel Ave, Tyler, TX 75701 Phone: 903-533-8702 Fax: 903-533-8720 | |
Dr. Margarita De La Garza-grahm, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1020 E Lake St, Tyler, TX 75701 Phone: 903-593-5500 Fax: 903-593-5408 | |
Chelsea Elizebeth Conder, CSFA Surgery Medicare: Not Enrolled in Medicare Practice Location: 1000 S Beckham Ave, Tyler, TX 75701 Phone: 903-597-0351 | |
Robert S Ellis, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 910 E Houston St, Ste 530, Tyler, TX 75702 Phone: 903-531-5560 | |
Dr. Robert A Mckinney Jr., MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 910 E Houston, Ste 550, Tyler, TX 75701 Phone: 903-592-7393 | |
Dr. Duane N Andrews, MD Surgery Medicare: Medicare Enrolled Practice Location: 910 E Houston St, Suite 550, Tyler, TX 75702 Phone: 903-592-7393 |